American Journal of Obstetrics & Gynecology
Volume 194, Issue 3 , Pages 681-686 , March 2006

Prevention of alcohol-induced learning deficits in fetal alcohol syndrome mediated through NMDA and GABA receptors

  • Laura Toso, MD

      Affiliations

    • Unit on Perinatal and Developmental Neurobiology, National Institute of Child and Human Development
    • National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD
    • Corresponding Author InformationReprint requests: Laura Toso, MD, UPDN, NICHD, NIH and NIAAA, NIH, Bldg 9, Room 1W125, 9 Memorial Drive MSC 0925, Bethesda, MD 20892-0925.
    • ,
  • Sarah H. Poggi, MD

      Affiliations

    • Unit on Perinatal and Developmental Neurobiology, National Institute of Child and Human Development
    • Department of Obstetrics and Gynecology, INOVA Hospital, Alexandria, VA
    • ,
  • Robin Roberson

      Affiliations

    • Unit on Perinatal and Developmental Neurobiology, National Institute of Child and Human Development
    • ,
  • Jade Woodard

      Affiliations

    • Unit on Perinatal and Developmental Neurobiology, National Institute of Child and Human Development
    • ,
  • Jane Park

      Affiliations

    • Unit on Perinatal and Developmental Neurobiology, National Institute of Child and Human Development
    • ,
  • Daniel Abebe

      Affiliations

    • Unit on Perinatal and Developmental Neurobiology, National Institute of Child and Human Development
    • ,
  • Catherine Y. Spong, MD

      Affiliations

    • Unit on Perinatal and Developmental Neurobiology, National Institute of Child and Human Development

Received 7 December 2005 ,Revised 5 January 2006 ,Accepted 7 January 2006.

References 

  1. American Academy of Pediatrics . Committee on Substance Abuse and Committee on Children with Disabilities. Fetal alcohol syndrome and alcohol-related neurodevelopmental disorders. Pediatrics. 2000;106:358–361
  2. Sokol RJ, Delaney-Black V, Nordstrom B. Fetal alcohol spectrum disorder. JAMA. 2003;290:2996–2999
  3. US Surgeon General Warning. Advisory on alcohol use during pregnancy. February 2005. Available at: http://www.hhs.gov/surgeongeneral/pressreleases/sg02222005.html. Accessed January 17, 2006.
  4. Centers for Disease Control and Prevention (CDC). Behavioral risk factor surveillance system. Atlanta, GA: US Department of Health and Human Services, CDC. Available at: http://www.cdc.gov/brfss. Accessed January 17, 2006.
  5. Toso L, Poggi SH, Abebe D, Roberson R, Dunlap V, Park J, et al. N-methyl-D-aspartate subunit expression during mouse development altered by in utero alcohol exposure. Am J Obstet Gynecol. 2005;193:1534–1539
  6. Barker JL, Behar T, Li YX, Liu QY, Ma D, Maric D, et al. GABAergic cells and signals in CNS development. Perspect Dev Neurobiol. 1998;5:305–322
  7. Toso L, Poggi SH, Woodard J, Abebe D, Spong CY. Prenatal alcohol exposure alters GABAAα5 expression: a mechanism of alcohol-induced learning dysfunction. Am J Obstet Gynecol. 2005;192:727–733
  8. Spong CY, Abebe DT, Gozes I, Brenneman DE, Hill JM. Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J Pharmacol Exp Ther. 2001;297:774–779
  9. Vink J, Auth J, Abebe DT, Brenneman DE, Spong CY. Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome. Am J Obstet Gynecol. 2005;193:825–829
  10. Webster WS, Walsh DA, Lipson AH, McEwen SE. Teratogenesis after acute alcohol exposure in inbred and outbred mice. Neurobehav Toxicol. 1980;2:227–234
  11. Spong CY, Lee SJ, McCune SK, Gibney G, Abebe D, Alvero R, et al. Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide. Endocrinology. 1999;140:917–924
  12. Zaltman R, Beni SM, Giladi E, Pinhasov A, Steingart RA, Pomano J, et al. Injections of the neuroprotective peptide NAP to newborn mice attenuate head-injury-related dysfunction in adults. Neropharm Toxicol. 2003;14:481–484
  13. Brenneman DE, Hauser J, Spong CY, Phillips TM. Chemiokines released from astroglia by vasoactive intestinal peptide. Mechanism of neuroprotection from HIV envelope protein toxicity. Ann NY Acad Sci. 2000;921:109–114
  14. Ashur-Fabian O, Segal-Ruder Y, Skutelsky E, Brenneman DE, Steingart RA, Giladi E, et al. The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide. Peptides. 2003;24:1423–1426
  15. Offen D, Sherki Y, Melamed E, Fridkin M, Brenneman DE, Gozes I. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease. Brain Res. 2000;854:257–262
  16. Gressens P. VIP neuroprotection against excitotoxic lesions of the developing mouse brain. Ann NY Acad Sci. 1999;897:109–124
  17. Chen SY, Charness ME, Wilkemeyer MF, Sulik KKP, Zouh F, Sari Y, et al. A neuroprotective peptide antagonizes fetal alcohol exposure-compromised brain growth. J Mol Neurosci. 2004;24:189–199
  18. Endres M, Toso L, Roberson R, Park J, Abebe D, Poggi S, et al. Prevention of alcohol-induced developmental delays and learning abnormalities in a model of fetal alcohol syndrome. Am J Obstet Gynecol. 2005;193:1028–1034
  19. Poggi SH, Goodwin KM, Hill JM, Brenneman DE, Tendi E, Schninelli S, et al. The role of activity-dependent neuroprotective protein in a mouse model of fetal alcohol syndrome. Am J Obstet Gynecol. 2003;189:790–793
  20. Spong CY, Auth J, Vink J, Goodwin K, Abebe DT, Hill JM, et al. Vasoactive intestinal peptide mRNA and immunoreactivity are decreased in fetal alcohol syndrome model. Regul Pept. 2003;108:143–147
  21. Brenneman DE, Hauser J, Neale E, Rubinraut S, Fridkin M, Davidson A, et al. Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides. J Pharmacol Exp Ther. 1998;285:619–627
  22. Gozes I, Divinski I. The femtomolar-acting NAP interacts with microtubules: novel aspects of astrocyte protection. J Alzheimers Dis. 2004;6:S37–S41
  23. White DM, Walker S, Brenneman DE, Gozes I. CREB contributes to increased neurite outgrowth of sensory neurons induced by vasoactive intestinal polypeptide and activity-dependent neurotrophic factor. Brain Research. 2000;868:31–38
  24. Sala C, Rudolph-Correira S, Sheng M. Developmentally regulated NMDA receptor-dependent dephosphorylation of cAMP response element-binding protein (CREB) in hippocampal neurons. J Neurosci. 2000;12:3529–3536
  25. Freund TF, Buzsàki G. Interneurons of the hippocampus. Hippocampus. 1996;6:347–470

 Presented at the 26th Annual Meeting of the Society for Maternal Fetal Medicine, Miami, FL, January 30-February 4, 2006.This work was supported by the Division of Intramural Research of National Institute of Child and Human Development.

PII: S0002-9378(06)00046-9

doi: 10.1016/j.ajog.2006.01.003

American Journal of Obstetrics & Gynecology
Volume 194, Issue 3 , Pages 681-686 , March 2006

Article Tools

* Image Usage & Resolution